Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA.
Microb Pathog. 2010 Mar-Apr;48(3-4):131-42. doi: 10.1016/j.micpath.2010.01.003. Epub 2010 Jan 22.
Escherichia coli O157:H7 is a food-borne pathogen that can cause hemorrhagic colitis and, occasionally, hemolytic uremic syndrome, a sequela of infection that can result in renal failure and death. Here we sought to model the pathogenesis of orally-administered E. coli O157:H7 in BALB/c mice with an intact intestinal flora. First, we defined the optimal dose that permitted sustained fecal shedding of E. coli O157:H7 over 7 days ( approximately 10(9) colony forming units). Next, we monitored the load of E. coli O157:H7 in intestinal sections over time and observed that the cecum was consistently the tissue with the highest E. coli O157:H7 recovery. We then followed the expression of two key E. coli O157:H7 virulence factors, the adhesin intimin and Shiga toxin type 2, and detected both proteins early in infection when bacterial burdens were highest. Additionally, we noted that during infection, animals lost weight and approximately 30% died. Moribund animals also exhibited elevated levels of blood urea nitrogen, and, on necropsy, showed evidence of renal tubular damage. We conclude that conventional mice inoculated orally with high doses of E. coli O157:H7 can be used to model both intestinal colonization and subsequent development of certain extraintestinal manifestations of E. coli O157:H7 disease.
产志贺毒素大肠杆菌 O157:H7 是一种食源性病原体,可引起出血性结肠炎,偶尔还会引起溶血性尿毒症综合征,这是感染的后遗症,可导致肾衰竭和死亡。在这里,我们试图用具有完整肠道菌群的 BALB/c 小鼠来模拟口服产志贺毒素大肠杆菌 O157:H7 的发病机制。首先,我们确定了允许持续 7 天(约 10^9 个菌落形成单位)粪便排出产志贺毒素大肠杆菌 O157:H7 的最佳剂量。接下来,我们监测了随时间推移肠道各部位产志贺毒素大肠杆菌 O157:H7 的负荷量,观察到盲肠始终是恢复产志贺毒素大肠杆菌 O157:H7 最高的组织。然后,我们追踪了两种关键的产志贺毒素大肠杆菌 O157:H7 毒力因子——黏附素 intimin 和志贺毒素 2 型的表达情况,并在感染早期细菌负荷量最高时检测到这两种蛋白。此外,我们注意到在感染过程中,动物体重减轻,约 30%的动物死亡。濒死动物的血液尿素氮水平也升高,尸检时显示肾小管损伤的证据。我们的结论是,用高剂量产志贺毒素大肠杆菌 O157:H7 经口接种的普通小鼠可用于模拟肠道定植和产志贺毒素大肠杆菌 O157:H7 疾病某些肠外表现的后续发展。